General Information of Drug (ID: DMNCVQT)

Drug Name
GM602
Indication
Disease Entry ICD 11 Status REF
Ischemic stroke 8B11.5Z Phase 2 [1]
Cross-matching ID
TTD ID
DW4J6M

References

1 ClinicalTrials.gov (NCT01221246) Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (GMAIS). U.S. National Institutes of Health.